HTA27 How Dual Branding of Drugs Impacts Reimbursement Decision in Multiple Myeloma?
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1159
https://www.valueinhealthjournal.com/article/S1098-3015(22)01360-2/fulltext
Title :
HTA27 How Dual Branding of Drugs Impacts Reimbursement Decision in Multiple Myeloma?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01360-2&doi=10.1016/j.jval.2022.04.1159
First page :
Section Title :
Open access? :
No
Section Order :
11034